It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Inducible nitric oxide synthase (iNOS) plays a crucial role in controlling growth of Mycobacterium tuberculosis (M.tb), presumably via nitric oxide (NO) mediated killing. Here we show that leukocyte-specific deficiency of NO production, through targeted loss of the iNOS cofactor tetrahydrobiopterin (BH4), results in enhanced control of M.tb infection; by contrast, loss of iNOS renders mice susceptible to M.tb. By comparing two complementary NO-deficient models, Nos2−/− mice and BH4 deficient Gch1fl/flTie2cre mice, we uncover NO-independent mechanisms of anti-mycobacterial immunity. In both murine and human leukocytes, decreased Gch1 expression correlates with enhanced cell-intrinsic control of mycobacterial infection in vitro. Gene expression analysis reveals that Gch1 deficient macrophages have altered inflammatory response, lysosomal function, cell survival and cellular metabolism, thereby enhancing the control of bacterial infection. Our data thus highlight the importance of the NO-independent functions of Nos2 and Gch1 in mycobacterial control.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Stylianou, Elena 2
; Crabtree, Mark J 1
; Harrington-Kandt, Rachel 2 ; Kolb, Anna-Lena 1 ; Diotallevi, Marina 1 ; Hale, Ashley B 1 ; Bettencourt, Paulo 2 ; Tanner, Rachel 2 ; Matthew K O’Shea 2 ; Matsumiya, Magali 2 ; Lockstone, Helen 3 ; Müller, Julius 2
; Fletcher, Helen A 4
; Greaves, David R 5 ; McShane, Helen 2 ; Channon, Keith M 1 1 Division of Cardiovascular Medicine, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK
2 Jenner Institute, University of Oxford, Oxford, UK
3 Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK
4 Department of Immunology and Infection, London School of Hygiene and Tropical Medicine, London, UK
5 Sir William Dunn School of Pathology, University of Oxford, Oxford, UK




